Antimicrobial Resistance Strategic documents EU Law and Competence to tackle... Food, drink and agriculture Strategic documents “A CAP FOR HEALTHY LIVING”... Healthy Economic Policy Strategic Documents THE EUROPEAN SEMESTER AND ROMA HEALTH...
Trade for Health (TTIP and CETA) Strategic documents How could CETA undermine public health... Universal access and affordable medicines Strategic documents EPHA Briefing | Will fast-tracking medicines...
Filter - AllNewsPress ReleaseReportBriefingBlog Post Annual Growth Survey 2017: EPHA's reaction Civil society criticises “Business As Usual” plans for implementing SDGs The European Semester and Roma health Europe must do much more to stop drug-resistant ‘superbugs’ EPHA Briefing on the Evaluation of the EU AMR Action Plan 2011-2016 EU law and competence to tackle antimicrobial resistance: What can the EU do? Is digital health inclusive for all? Spotlight on COPD in Hungary When CETA met its Waterloo – the battle over the EU-Canada deal continues Europe and AMR: Adding more value… or passing the buck? Soft drinks lobby uses self-serving self-regulation to undermine policy on advertising, leaked emails show Public health groups call for EU target and action on serious road injuries Scottish Court gives green light to Minimum Unit Pricing Antibiotic factories compounding superbug spread Europe’s social dimension needs intensive care EU-Canada ‘CETA’ trade deal blazes a trail for TTIP NGOs ask the European Parliament to call time on unhealthy and manipulative marketing to children Communicating drug-resistance: Making the intangible tangible Addressing the grey zone – mobile apps, health and other uses Europe’s Role in Activating Global Action on drug-resistant ‘superbugs’